SCHEMBL23090386

SCHEMBL23090386

COc1cc2c(cc1C(=O)Nc1ccc(-c3ccccc3)cn1)CCCCC2

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 4/20 0.61
▸ ABCC1 P33527 3/20 0.61
▸ RAB9A P51151 5/20 0.53
▸ NPC1 O15118 4/20 0.53
▸ KMT2A Q03164 4/20 0.53
▸ RXFP1 Q9HBX9 2/20 0.53
▸ DHODH Q02127 3/20 0.52
▸ MEN1 O00255 3/20 0.52
▸ LMNA P02545 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ MITF O75030 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23090371 0.84 DHODH (0.71) ABCB1ABCC1RAB9ANPC1KMT2A
SCHEMBL23090412 0.82 DHODH (0.71) ABCB1ABCC1RAB9ANPC1KMT2A
SCHEMBL1702049 0.81 RAB9A (0.61) ABCB1ABCC1RAB9ANPC1KMT2A
SCHEMBL23090415 0.80 MEN1 (0.62) RAB9ANPC1KMT2ADHODHMEN1
SCHEMBL1701695 0.78 KMT2A (0.58) ABCB1ABCC1RAB9ANPC1KMT2A
SCHEMBL1702137 0.73 LMNA (0.50) ABCB1ABCC1RAB9ANPC1KMT2A
SCHEMBL23090396 0.71 DHODH (0.53) RAB9ANPC1KMT2ARXFP1DHODH
SCHEMBL12156049 0.70 NPC1 (0.56) ABCB1ABCC1RAB9ANPC1KMT2A
SCHEMBL12156132 0.70 STIM1 (0.61) RAB9ANPC1KMT2AMEN1LMNA
SCHEMBL23090387 0.70 RAB9A (0.53) RAB9ANPC1KMT2ADHODHMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS ZC3HAV1, MAVS, ZC3HAV1L ABCB1 1462/4885ABCC1 3692/4885RAB9A 1095/4885
US-11066357-B2 Benzoannulene derivatives as antiviral agents ZC3HAV1, MAVS, ZC3HAV1L ABCB1 1462/4885ABCC1 3692/4885RAB9A 1095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback